Drug Discovery

Explore how generative AI and automation are transforming drug discovery with faster design, synthesis, and testing cycles. Learn about business impact and future prospects.

Discover how AI is transforming drug development, closing the divide between large pharmaceutical firms and biotech startups through faster discovery, smarter trials, and innovative collaborations.

Explore how practical AI applications, data integrity, and human-relevant biological models are transforming drug discovery into a precise and reliable process.

Discover how Expedition Medicines, backed by Flagship Pioneering and partnered with Pfizer, uses an AI-driven quantum chemistry platform to create novel therapies for undruggable proteins in oncology and immunology.

Flagship Pioneering introduces Expedition Medicines, backed by $50M funding, employing AI and covalent chemistry to develop new treatments for cancer and immune diseases with Pfizer collaboration.

Explore how chemistry-aware AI, exemplified by Iktos’s Makya platform, is overcoming synthesis challenges in AI drug discovery to accelerate small molecule design and improve drug development.

Explore how artificial intelligence accelerates drug discovery by streamlining target identification, compound screening, and clinical trial design in pharmaceuticals.

Explore how Merck and Siemens combine pharmaceutical R&D and advanced AI platforms to transform drug discovery and development, shaping the future of biopharma innovation.

Discover how the US-UK technology partnership is accelerating AI-driven drug discovery, fostering healthcare innovation, creating jobs, and boosting economic growth.

Explore the impact of artificial intelligence on drug discovery, from speeding up target identification to overcoming challenges in pharmaceutical R&D.